Home
Conditions
Pulmonary Arterial Hypertension (PAH)

Clinical trial condition

Pulmonary Arterial Hypertension (PAH)

Explore clinical trials studying Pulmonary Arterial Hypertension (PAH). Study availability and eligibility vary by location and protocol.

42 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension (PAH) trial results

Not Yet Recruiting

Information Sources in Pulmonary Hypertension

NCT07207525

Conditions: Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +5 more
Locations: Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo São Paulo, Brazil

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension

NCT07177703

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes

NCT07082933

Conditions: Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Ambrisentan for Early Low-Risk Pulmonary Arterial Hypertension

NCT06987097

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +2 more
Locations: Not specified

View Trial Details

Completed

Incorporating the Venous Excess Ultrasound Score (VExUS Score) Into Contemporary Haemodynamic Risk Assessment in Pulmonary Arterial Hypertension: The INVEXUS-PAH Study

NCT07266012

Conditions: Cardiovascular Diseases, Hyperemia, Hypertension, Pulmonary, +6 more
Locations: Istanbul University-Cerrahpasa Institute of Cardiology Istanbul, FATIH, Turkey (Türkiye)

View Trial Details

Completed

Bioequivalence Study to Compare Selexipag 400mcg Film Coated Tablets (400 mcg Selexipag) Versus Uptravi® 400mcg Film Coated Tablets (400 mcg Selexipag)

NCT06932198

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +2 more
Locations: ACDIMA Center Amman, Jordan

View Trial Details

Completed

(RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment)

NCT03362047

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +2 more
Locations: Klinik III für Innere Medizin Herzzentrum der Universität zu Köln Cologne, Germany

Abteilung Pneumologie und Intensivmedizin der Medizinischen Klinik II, Uniklinik Gießen und Marburg Standort Gießen Giessen, Germany

Krankenhaus Neuwittelsbach, Innere Medizin II München, Germany

View Trial Details

Completed

Safety and Effectiveness of a Virtual Pediatric Cardiac Rehabilitation Program or Telerehabilitation in Children With Heart Disease

NCT06819059

Conditions: Cardiac Rehabilitation, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations: Columbia University Medical Center - New York Presbyterian's Morgan Stanley's Children's Hospital New York, United States

View Trial Details

Completed

Effects of UE Aerobic Exercise on Exercise Capacity and PA in Patients With Pulmonary Arterial Hypertension.

NCT05947240

Conditions: Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +2 more
Locations: National hospital and Ittefaq hospital in Lahore Lahore, Punjab Province, Pakistan

View Trial Details

Completed

ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy

NCT03145298

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

View Trial Details

Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension (PAH) trial results

Related conditions